Resource Utilization Reduction for Evaluation of Chest Pain in Pediatrics Using a Novel Standardized Clinical Assessment and Management Plan (SCAMP)

Journal of the American Heart Association
George R VergheseDavid R Fulton

Abstract

Chest pain is a common reason for referral to pediatric cardiologists. Although pediatric chest pain is rarely attributable to serious cardiac pathology, extensive and costly evaluation is often performed. We have implemented a standardized approach to pediatric chest pain in our pediatric cardiology clinics as part of a broader quality improvement initiative termed Standardized Clinical Assessment and Management Plans (SCAMPs). In this study, we evaluate the impact of a SCAMP for chest pain on practice variation and resource utilization. We compared demographic variables, clinical characteristics, and cardiac testing in a historical cohort (n=406) of patients presenting to our outpatient division for initial evaluation of chest pain in the most recent pre-SCAMP calendar year (2009) to patients enrolled in the chest pain SCAMP (n=364). Demographic variables including age at presentation, sex, and clinical characteristics were similar between groups. Adherence to the SCAMP algorithm for echocardiography was 84%. Practice variation decreased significantly after implementation of the SCAMP (P<0.001). The number of exercise stress tests obtained was significantly lower in the SCAMP-enrolled patients compared with the historic cohor...Continue Reading

References

Jun 1, 1984·Clinical Pediatrics·D A Fyfe, D S Moodie
Mar 1, 1995·Pediatric Cardiology·F S TunaogluS Demirsoy
Aug 10, 1996·BMJ : British Medical Journal·I G McDonaldJ M Gutman
Apr 28, 1999·Pediatric Clinics of North America·K C Kocis
Jan 6, 2001·Journal of Pediatric Health Care : Official Publication of National Association of Pediatric Nurse Associates & Practitioners·J A EvangelistaA K Renneburg
Oct 24, 2003·The New England Journal of Medicine·Elliott S Fisher
Apr 20, 2004·Clinical Pediatrics·Martial M MassinPaul Gérard
Feb 29, 2008·Pediatric Cardiology·Michael J DanduranPeter C Frommelt
Jul 27, 2010·Congenital Heart Disease·Rahul H RathodJames E Lock
Oct 12, 2011·Pediatrics·Susan F SaleebJames E Lock

❮ Previous
Next ❯

Citations

Dec 19, 2015·Pediatric Annals·Tisha K Yeh, Jay Yeh
Apr 4, 2017·The Journal of Pediatrics·Tuan NguyenLeo Lopez
Mar 6, 2017·Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography·Ritu SachdevaWilliam L Border
Jun 28, 2017·Congenital Heart Disease·Jimmy C LuRoy Jedeikin
May 17, 2017·Current Opinion in Pediatrics·Patricia E Acra, María T Pérez
Jul 12, 2018·Clinical Pediatrics·Nupur N DalalAshraf S Harahsheh
Feb 21, 2016·Journal of the American Heart Association·Yvonne ParisUNKNOWN New England Congenital Cardiology Association (NECCA)
Sep 17, 2016·Journal of Pediatric Orthopedics·Gaurav LutherDonald S Bae
Nov 9, 2016·Pediatric Cardiology·Sean M LangR Thomas Collins
Feb 11, 2020·Cardiology in the Young·Daniel S ZiebellChristopher J Statile
Nov 20, 2016·Congenital Heart Disease·Sean M LangR Thomas Collins
Sep 26, 2017·Congenital Heart Disease·Susan F SaleebDavid R Fulton
Jul 30, 2015·Congenital Heart Disease·Andrew Y ShinXuefeng B Ling
Mar 7, 2019·Journal of Pediatric Orthopedics·Gaurav LutherDonald S Bae
Nov 16, 2019·European Journal of Pediatrics·Valentina GesueteGiorgio Cozzi
Feb 15, 2021·Pediatric Cardiology·Melissa M WinderCollin G Cowley
May 31, 2019·The Journal of Thoracic and Cardiovascular Surgery·Rebecca A BertrandtRonald K Woods

❮ Previous
Next ❯

Software Mentioned

SCAMPs
SPSS
Plus

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.